“Does the Claimant allege that it acquired Glencore shares 'as part of': (i) the IPO; (ii) the Merger and/or (iii) aftermarket for the IPO and/or the Merger? Please specify which.”
“If the Claimant allege to have acquired Glencore shares in the aftermarket for the IPO and/or Merger, what period of time constitutes the aftermarket?”
“Where a Pallas Claimant is indicated to have acquired IPO Shares, it is a Pallas IPO Claimant, and where it is indicated to have acquired Merger Shares, it is a Pallas Merger Claimant. For these purposes, a Pallas IPO Claimant is a Pallas Claimant that acquired Shares as part of Glencore's IPO and/or in the aftermarket thereof, where such aftermarket runs up to and including1 May 2013 (the 'Pallas IPO Period'). A Pallas Merger Claimant is a Pallas Claimant that acquired Shares as part of the Merger and/or in the aftermarket thereof, being the period from2 May 2013 to15 September 2015 (the 'Pallas Merger Period').”
"If the Claimant held the Glencore shares indirectly, please provide full particulars of the chain of custody, including identity of any custodian, depositary, sub-custodian, nominee and/or legal title/registered holder, as applicable."
“It seems to me that the Claimants, having brought the action, should be prepared to undertake substantial work in ensuring the expeditious progress of the proceedings to resolution. That includes giving disclosure, preparing witness statements, and being prepared to provide evidence at trial.”
“... the parties know[ing] what the other side's case is, and as to all its constituent elements, including quantum, so that decisions, including in relation to settlement, can be based on the fullest information.”
“The IPO Claimants claim, for each of the Shares acquired in the IPO or in the aftermarket, the price paid (£5.30 per share where acquired in the IPO) less a certain figure, depending upon the applicable measure of loss. The applicable deductions and measures of loss (not in any order of priority) are: 140.1. The sum actually received upon re-sale of the Shares, insofar as each individual IPO Claimant re-sold the Shares (the 'Actual Sale Measure'); 140.2. Alternatively, the true value of the shares as at the date of acquisition, which is a matter for expert evidence at trial but is likely to be substantially less than the price paid for the Shares (the 'Loss on Acquisition Measure'); 140.3. Alternatively, the market price of the shares at such date determined by the Court on which full information as to the true position became generally available and after which any retention of the shares can be deemed to be an independent decision of the shareholder (the 'Date of Discovery Measure'); 140.4. Alternatively, such measure of loss as the Court shall find is applicable to a claim, the measure of loss under s90 of FSMA currently being free from binding authority.”
“before an application is made to the court for an order under Part 18, the party seeking clarification or information should first serve on the party from whom it is sought a written request for that clarification, stating a date by which a response should be served and that date must allow the second party a reasonable time to respond.”
“Documents disclosed by the Glencore Group to the relevant authorities in the: 1.1. DOJ Investigation; 1.2. Brazilian Investigation; 1.3. CFTC Investigation; 1.4. SFO Investigation; 1.5. Swiss Investigation; 1.6. OSC Investigation; and 1.7. Netherlands, with respect to the investigation conducted by the Dutch authorities (together the 'Investigations').”
“3.1. At the material times, what knowledge or suspicions, if any, did the following individuals have of the bribery and corruption alleged in Section B of the CPOC relating to West Africa and South Sudan, and/or were they reckless and/or did they turn a blind eye to the same, and if so, when: (a) the Director Defendants; (b) Mr Beard; and (c) Mr Gibson?”
“We refer to [the Judge’s], request at the conclusion of yesterday's hearing that the parties devise a form of words in respect of category 1. Glencore proposes the following: (a) Glencore will work with WilmerHale and PwC to identify any production in relation to which it is apparent, without reviewing the documents contained within that production, that the entirety of the documents in an individual production are relevant to the issues for disclosure. (b) Insofar as there are any such productions, Glencore will state its position as to the proportionality of providing any such production by way of early disclosure, taking into account the need to conduct a detailed review of documents within such production for privilege. This will be provided by17 June 2024 ...”
“By7 June 2024 , the first Defendant (i) produce all requests whether for voluntary production or pursuant to statutory powers of compulsion made by the law enforcement authorities in response to which the 400 productions (as described in paragraph 30 of Tolaini 2) were disclosed; (ii) to the extent not specified in the request, confirm the list of keywords to which each of the productions was responsive; (iii) identify which of the productions made in response to these requests were reviewed for privilege under English law.”
“It is declared that insofar as any documents that the First Defendant would otherwise be required to produce are privileged, the First Defendant shall be entitled to withhold production of such documents from each of the Claimants on the grounds of privilege (subject to it being determined or otherwise agreed that the First Defendant has waived privilege in such documents, or privilege otherwise being lost).”
“So far it seems to me that the authorities are all consistent. There is a general rule that no privilege can be asserted by the company against its shareholders. The general rule is subject to an exception where the advice taken by the company is in relation to litigation - that litigation being actual, threatened or in contemplation.”
“The foundation, as I understand it, of the general rule is the same as the foundation of the similar general rule that applies in the case of trustees and beneficiaries. Just as a trustee who takes advice as to his duties in relation to the running of a trust, and pays for it out of the trust assets cannot assert privilege against the beneficiaries who have, indirectly, paid for that advice, so too a company taking advice on the running of the company's affairs and paying for it out of the company's assets cannot assert a privilege against the shareholders who, similarly, have indirectly paid for it.”